Clinical and Cancer Genetics Lead, West Midlands Regional Genetics Service

After rotations in adult general medicine and paediatrics, Trevor’s specialist training in clinical genetics was undertaken at the Institute of Medical Genetics in Cardiff and the Research Institute in Toronto funded by Action Research and the Pathological Society of Great Britain and Ireland. In 1992 he was appointed to his current post.

As lead for the West Midlands cancer genetics services in the 1990’s he developed and implemented clinical pathways for the management of inherited cancers and integrated molecular testing to improve the efficacy of management. He later expanded integration of medical genetics into a wide range of mainstream specialities with support from a Department of Health pilot project grant (£500K).

His current clinical interests now lie mostly in cancer syndromes, overgrowth disorders (current NIHR funding for PhD studentship), endocrine genetic disorders and translational research with introduction of new genetic technologies, including free DNA analysis and genomic technologies into mainstream practice.

His current research on the use of free DNA for non invasive prenatal diagnosis is funded by a Department of Health and  Wellcome Foundation HICF award and in field of paediatric cancer by a Wellcome Pathfinder award.

Trevor is a current member of Clinical Genetics CRG (Deputy Chair), a member of Health Education England’s Genomics Advisory Board, and is the rare disease lead for the West Midlands Genomic Medicine Centre.